scorecardresearch
Add as a preferred source on Google
Friday, January 23, 2026
TopicCentral Drugs Standard Control Organization

Topic: Central Drugs Standard Control Organization

Drug regulator’s latest guidelines on recall lack teeth, legal backing, have too many ‘loopholes’

Public health activists say unless drug recall policy with legal backing is brought in, guidelines will not serve any purpose; ask who has ultimate authority to verify all batches are recalled.

India denies nod to ‘1st-ever weekly insulin’ for diabetics, seeks more info from maker Novo Nordisk

Icodec has been touted as a therapy that could eliminate the need for daily or mealtime insulin injections for people with severe diabetes. It has not been approved by any country so far.

Global pharma majors pitch for faster approval of innovative drugs in India but CDSCO remains cautious

Organisation of Pharmaceutical Producers of India seeks nod for drugs to be marketed at same time as US, Europe. But regulator rarely permits a drug launch without local clinical trials.

Drug regulator initiates move to control tapentadol & pregabalin sale amid reports of growing misuse

India's apex drug regulator will form a panel to examine whether more regulatory restrictions should be put in place. Experts say more curbs a good idea but implementation is key.

2 cough syrups found ‘contaminated’, regulator launches probe into Gujarat drugmaker

CDSCO says two cough syrups manufactured by Ankleshwar-based Norris Pharma were found to contain Ethylene Glycol (EG) & Diethylene Glycol (DEG) beyond acceptable limits.

Drugs regulator to probe ‘faulty’ optical lens by Swiss-American firm Alcon

The Central Drugs Standard Control Organisation has formed an inquiry committee following a complaint by ophthalmologist and ex-parliamentarian Dr Vikas Mahatme.

CDSCO probing cough syrups made by Haryana firm that ’caused 66 kids’ deaths in The Gambia’

WHO alerted Indian authorities of possible link between the deaths and four cough and cold medicines made by Sonepat-based Maiden Pharmaceuticals on 29 September, it is learnt.

Pune cell science centre could soon get Modi govt nod to test and approve Covid vaccines

If given a go-ahead, National Centre for Cell Science will be the 2nd centre after Central Drugs Laboratory, Kasauli, to test Covid-19 vaccines.

Why India’s expert panel rejected Pfizer plea for emergency use nod to its Covid vaccine

The Drug Controller General of India has in the past rejected several applications from other drugmakers, including Dr Reddy Laboratory and Natco Pharma.

Govt panel rejects emergency-use approval for Dr Reddy’s Russian-origin potential Covid drug

The company had requested for waiver of clinical trials in India as a condition to market the monoclonal, antibody-based drug, Olokizumab.

On Camera

Controversial dog-walker IAS Sanjeev Khirwar is back in Delhi. What happened to his wife?

In 2022, athletes claimed they were asked to wind up training early at Thyagraj Stadium so that the IAS couple could walk their dog. Then came the memes and public outrage.

IndiGo profit plunges 78% as Dec meltdown with 3k flight cancellations takes a toll

Net income for InterGlobe Aviation Ltd slipped 78 percent to Rs 5.5 billion for the three months ended Dec 31 compared with the year-ago period.

Rafale saga: 25 yrs of detours, deadlocks & political hesitation. Now IAF getting what it always wanted

Instead of buying more Mirages outright in early 2000s, the requirement was tweaked in favour of a medium-weight, multi-role fighter with Mirage-like performance. 

Pakistan se azaadi. Grow up India, stop giving it prime real estate in your psyche

Pakistan not only has zero chance of catching up with India in most areas, but will inevitably see the gap rising. Its leaders will offer its people the same snake oil in different bottles.